Canadian Pharmacist's Letter
July Issue
 Summer brings questions about how to manage tick bites
 Invokana (in-vo-KAHN-uh, canagliflozin), as the first in a new class of oral drugs for type 2 diabetes
 All Current Issue topics...
 View June Issue

 Browse Categories
 Bone/Joint and Rheumatology
 Diabetes and Endocrinology
 More Categories...

Exit Mobile

Login  | Issues  | Feedback  | Search  | Browse  | New Drugs  | Email Us  | More >

[*]Top | [#]Bottom